We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
To send content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about sending content to .
To send content items to your Kindle, first ensure no-reply@cambridge.org
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about sending to your Kindle.
Note you can select to send to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
This chapter reviews the current knowledge of the molecular mechanisms controlling embryonic lung development in animal models from the initial specification of a small number of respiratory progenitor cells in the ventral foregut endoderm through the formation of the mature adult lung with regionally specialized epithelial, interstitial, and vascular compartments. In the second half of this chapter we introduce induced pluripotent stem cells (iPSCs) as a compelling new platform to study human lung biology at developmental time-points previously inaccessible to researchers. iPSCs offer the potential to generate functional lung tissue in vitro by translating the knowledge gained from studying respiratory system development in different animal models where many of the signaling pathways or airway branching mechanisms are evolutionarily conserved. There are many exciting possible applications of iPSC-derived lung tissue, including the ability to model human lung disease, screen novel drug therapies, and ultimately generate functional, transplantable lung cells or 3-D tissues for those suffering from one of the many forms of end-stage lung disease.
Recommend this
Email your librarian or administrator to recommend adding this to your organisation's collection.